Phase I/II trial of capecitabine, oxaliplatin, and irinotecan in combination with bevacizumab in first line treatment of metastatic colorectal cancer

Publisher: John Wiley & Sons Inc

E-ISSN: 2045-7634|2045-7634|10|1505-1513

ISSN: 2045-7634

Source: Cancer Medicine, Vol.2045-7634, Iss.10, 2015-10, pp. : 1505-1513

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content